Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS29P30 refers to a processed pseudogene derived from the ribosomal protein S29 gene (RPS29). Pseudogenes like RPS29P30 arise throughout the genome as copies of functional genes but typically lack regulatory elements or have mutations that prevent protein coding and cellular function. Unlike ribosomal protein S29, which plays an essential role in ribosome function and has relevance in Diamond-Blackfan anemia and oncogenesis[1][2][3][4][5], RPS29P30 does not encode an active protein and its biological or clinical significance has not been established. It is catalogued primarily for genomic annotation purposes and is not considered a therapeutic or diagnostic target[7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein S29 pseudogene 30 (RPS29P30).